Вы искали: established (Португальский - Итальянский)

established
stabilito

treatment of established osteoporosis in postmenopausal women
treatment of established osteoporosis in postmenopausal women

target2 is established and functions on the basis of the ssp .
target2 is established and functions on the basis of the ssp .

the bank has firmly established its inflation-fighting credentials .
the bank has firmly established its inflation-fighting credentials .

participants » final balances shall be established within one hour ;
participants » final balances shall be established within one hour ;

sabem o que querem e tem established relationships com a comissão.
sanno cosa vogliono ed hanno già dei rapporti consolidati, established relationships, con la commissione.

please note that the ecb is a public body established under the ec treaty ;
please note that the ecb is a public body established under the ec treaty ;

[11] four tests of occupancy as established in john laing and son, ltd.
[11] four tests of occupancy as established in john laing and son, ltd.

( ii ) participants » final balances shall be established within one hour ;
( ii ) participants » final balances shall be established within one hour ;

note for guidance on the non- clinical documentation of medicinal products with well- established use
note for guidance on the non-clinical documentation of medicinal products with well-established use

a transaction fee calculated on the same basis as the schedule established for direct participants in paragraph 1 of this appendix .
a transaction fee calculated on the same basis as the schedule established for direct participants in paragraph 1 of this appendix .

( a ) the payment message complies with the rules established by the network service provider ;
( a ) the payment message complies with the rules established by the network service provider ;

( c ) a transaction fee calculated on the same basis as the schedule established for direct participants in paragraph 1 of this appendix .
( c ) a transaction fee calculated on the same basis as the schedule established for direct participants in paragraph 1 of this appendix .

(6) the salmon farming loan assistance was established in 2000 for the purpose of providing working capital loans to individual salmon farming companies.
(6) the salmon farming loan assistance was established in 2000 for the purpose of providing working capital loans to individual salmon farming companies.

(2) wrap is an entity established to promote sustainable waste management, and more specifically to promote efficient markets for recycled materials and products.
(2) wrap is an entity established to promote sustainable waste management, and more specifically to promote efficient markets for recycled materials and products.

according to the rules applicable may be granted up to 60 % of eligible cost, thus also the rate of aid is compatible with the conditions established in the respective guidelines applicable at the time the aid was granted.
according to the rules applicable may be granted up to 60 % of eligible cost, thus also the rate of aid is compatible with the conditions established in the respective guidelines applicable at the time the aid was granted.

since the debt level of the tote would be lower than if the racing trust had to pay the true market value, it would enjoy greater facility to borrow from capital markets for upcoming investment programmes, competing directly with the established bookmakers.
since the debt level of the tote would be lower than if the racing trust had to pay the true market value, it would enjoy greater facility to borrow from capital markets for upcoming investment programmes, competing directly with the established bookmakers.

( e ) ancillary systems that require liquidity in the early morning need to have established means to cope with cases where the daytime processing cannot be started in time due to an ssp failure on the previous day .
( e ) ancillary systems that require liquidity in the early morning need to have established means to cope with cases where the daytime processing cannot be started in time due to an ssp failure on the previous day .

63) note for guidance on photosafety testing points to consider document on the need for assessment of reproductive toxicity of human insulin analogues discussion paper on environmental risk assessments of non- gmo containing medicinal products for human use non- clinical documentation of medicinal products with ‘ well- established use ’ note for guidance on the need for non- clinical testing of pharmaceuticals in juvenile animals discussion paper on the non- clinical safety studies to support single low dose clinical screening studies in man note for guidance on specification limits for residues for heavy metal catalysts in medicinal products points to consider on xenogeneic cell therapy note for guidance on comparability of biotechnology products pre- clinical and clinical issues points to consider on the assessment of the potential for qt interval prolongation by non- cardiovascular medicinal products note for guidance on risk assessment of medicinal products on human reproductive and development toxicities: from data to labelling
63) note for guidance on photosafety testing points to consider document on the need for assessment of reproductive toxicity of human insulin analogues discussion paper on environmental risk assessments of non-gmo containing medicinal products for human use non-clinical documentation of medicinal products with ‘ well-established use’ note for guidance on the need for non-clinical testing of pharmaceuticals in juvenile animals discussion paper on the non-clinical safety studies to support single low dose clinical screening studies in man note for guidance on specification limits for residues for heavy metal catalysts in medicinal products points to consider on xenogeneic cell therapy note for guidance on comparability of biotechnology products pre-clinical and clinical issues points to consider on the assessment of the potential for qt interval prolongation by non-cardiovascular medicinal products note for guidance on risk assessment of medicinal products on human reproductive and development toxicities: from data to labelling